1058-55-5 Usage
Uses
Used in Pharmaceutical Research:
(6alpha,11beta)-6-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate is used as a research tool for investigating the role of progesterone and its derivatives in various biological processes. Its application aids in understanding the interactions of these compounds with hormone receptors, which is crucial for developing targeted therapies.
Used in Drug Development:
In the pharmaceutical industry, (6alpha,11beta)-6-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate serves as a key intermediate in the synthesis of hormone-based therapeutics. Its unique structural features make it a promising candidate for the development of novel drugs with potential applications in treating hormone-related disorders.
Used in Hormone Receptor Studies:
(6alpha,11beta)-6-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate is employed as a ligand in the study of hormone receptor interactions. This application is vital for elucidating the mechanisms of hormone action and for designing drugs that can modulate these interactions effectively.
Used in Hormone-Based Therapies:
(6alpha,11beta)-6-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate is utilized as a starting material or a structural component in the development of hormone-based therapies. Its incorporation into drug formulations can potentially enhance the efficacy of treatments for conditions influenced by hormonal imbalances or hormone receptor dysfunction.
Check Digit Verification of cas no
The CAS Registry Mumber 1058-55-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,5 and 8 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1058-55:
(6*1)+(5*0)+(4*5)+(3*8)+(2*5)+(1*5)=65
65 % 10 = 5
So 1058-55-5 is a valid CAS Registry Number.
1058-55-5Relevant academic research and scientific papers
Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid
-
, (2008/06/13)
This invention discloses an improved process for the production of corticoids from 17α-hydroxy steroids utilizing peroxymonosulfate.
